Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hormones and genes affect hair growth and male baldness.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Increased PPARGC1α relates to hair thinning in common baldness.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

A new method accurately measures nine specific hormones in human blood.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Excess androgens may cause PCOS, not just be a symptom.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hyperthyroidism can hide signs of high androgen levels in females.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.